# Pitfalls When Determining HNA-1 Genotypes and Finding Novel Alleles

**Authors:** Kirstine Kløve-Mogensen, Tom Browne, Thure Mors Haunstrup, Rudi Steffensen

PMC · DOI: 10.3390/ijms25169127 · International Journal of Molecular Sciences · 2024-08-22

## TL;DR

This paper shows that current methods for determining HNA-1 genotypes are inaccurate, while long-read nanopore sequencing offers a more precise and comprehensive solution.

## Contribution

The study introduces long-read nanopore sequencing as a novel and specific method for FCGR3B genotyping, overcoming limitations of existing techniques.

## Key findings

- Long-read nanopore sequencing accurately detects FCGR3B alleles and dosage-dependent distributions.
- Current genotyping methods like TaqMan PCR and PCR-SSP produce ambiguous results due to co-amplification with FCGR3A.
- Nanopore sequencing can identify novel and rare FCGR3B variants previously undetected.

## Abstract

Genetic variation in the FCGR3B gene is responsible for different variants of human neutrophil antigen 1 (HNA-1). Laboratory techniques currently utilized for routine HNA-1 genotyping, predominantly PCR-sequence-specific primer (PCR-SSP) and PCR-sequence-based typing (PCR-SBT), lack specificity for FCGR3B. This study compares the capabilities and limitations of existing technologies including an in-house TaqMan PCR, a commercial PCR-SSP test, PCR-SBT and multiplex ligation-dependent probe amplification (MLPA) with those of a long-read nanopore sequencing assay. Testing was performed with both related and unrelated Danish samples with different copy numbers and/or rare alleles. Long-read nanopore sequencing was validated by blind testing of ten English samples. The results showed that FCGR3B copy numbers correlate with a dose-dependent distribution of alleles that complicates genotyping by TaqMan PCR, PCR-SSP and PCR-SBT, due to co-amplification of the homologous FCGR3A gene. MLPA can correctly quantify the dose-dependent distribution but not detect novel variants. Long-read nanopore sequencing showed high specificity for FCGR3B and was able to detect dosage-dependent distribution, and rare and novel variants that were previously not described. Current HNA-1 genotyping methods cannot produce unambiguous allele-level results, whereas long-read nanopore sequencing has shown the potential to resolve observed ambiguities, identify new HNA-1 variants and allow definitive allele assignment.

## Linked entities

- **Genes:** FCGR3B (Fc gamma receptor IIIb) [NCBI Gene 2215], FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214]

## Full-text entities

- **Genes:** FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, FCGR3B (Fc gamma receptor IIIb) [NCBI Gene 2215] {aka CD16, CD16-I, CD16b, FCG3, FCGR3, FCRIIIb}
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11354314/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11354314/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC11354314/full.md

---
Source: https://tomesphere.com/paper/PMC11354314